Generation of dendritic cells from peripheral blood adherent cells in medium with human serum

Scandinavian Journal of Immunology

Volumn 47, Issue 2, 1998, Pages 116-121

  Anton, D ^a   Dabadghao, S ^a   Palucka, K ^a   Holm, G ^a   Yi, Q ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD1 ANTIGEN; CD40 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ARTICLE; BLOOD; CELL CULTURE; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; SERUM; T LYMPHOCYTE;

ADULT; ANTIGEN PRESENTATION; ANTIGENS, CD; CELL SEPARATION; CELLS, CULTURED; CULTURE MEDIA; DENDRITIC CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031938507     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00284.x     Document Type: Article

References (25)

1. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973;137:1142-62.
2. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991;9:271-96.
3. Caux C, Liu Y-J, Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 1995;16:2-4.
4. Romani N, Koide S, Crowley M et al. Presentation of exogenous protein antigens by dendritic cells to T cell clone: intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 1989;169:1169-178.
5. + helper T cells. J Exp Med 1990;171:1315-332.
6. Larsen CP, Ritchie SC, Hendrix R et al. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol, 152;5208-5219.
7. Grabbe S, Beissert S, Schwarz T et al. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol Today 1995;16:117-21.
8. Girolomoni G, Ricciardi-Castagnoli P. Dendritic cells hold promise for immunotherapy. Immunol Today 1997;118:102-104.
9. Inaba K, Inaba M, Romani N et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693-1702.
10. Inaba K, Steiman RM, Witmer-Pack M et al. Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med 1992;175:1157-167.
11. Reid CD, Stackpoole A, Meager A et al. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol 1992;149:2681-2688.
12. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNFα. J Exp Med 1996;184:695-706.
13. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J Exp Med 1994;179:1109-1118.
14. Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
15. Romani N, Reider D, Heuer M et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996;196:137-51.
16. Bender A, Sapp M, Schuler G et al. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 1996;196:121-35.
17. Lundgren G, Zukoski CHF, Möller G. Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol 1968;3:817-36.
18. Romani N, Schuler G. The immunological properties of epidermal Langerhans cells as part of the dendritic cell system. Springer Semin Immunopathol 1992;13:265-79.
19. Austyn JM. Antigen uptake and presentation by dendritic leukocytes. Semin Immunol 1992;4:227-36.
20. Inaba K, Metlay JP, Crowley MT et al. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 1990;172:631-40.
21. Mayordomo JI, Loftus DJ, Sakamoto H et al. Therapy of murine tumors with p. 53 wild-type and mutant sequence peptide-based vaccines. J Exp Med 1996;183:1357-1365.
22. Young JW, Inaba K. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted anti-tumor immunity. J Exp Med 1996;183:7-11.
23. Paglia P, Chiodoni C, Rodolfo M et al. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 1996;183:317-22.
24. Puré E, Inaba K, Crowley MT et al. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J Exp Med 1990;172:1459-1469.
25. Bhardwaj N, Young JW, Nisanian AJ et al. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J Exp Med 1993;178:633-42.